What is the typical dosage of sandostatin for acromegaly?

What is the typical dosage of Sandostatin for acromegaly?

Sandostatin (octreotide acetate) treats acromegaly by suppressing excess growth hormone. The typical initial dose is 50 mcg injected subcutaneously three times daily. After two weeks, dose titration occurs based on growth hormone and IGF-1 levels, with most patients reaching an effective range of 100–200 mcg three times daily. Some patients may require 500 mcg three times daily.

How does Sandostatin LAR compare to immediate-release Sandostatin?

Sandostatin LAR is the long-acting release version that receives injections once every four weeks. The initial dose is 20 mg intramuscularly. After two or three months, dose adjustment occurs based on hormone levels. Patients switching from immediate-release Sandostat in typically receive the 20 mg monthly dose when they receive their final daily dose.

How long does Sandostatin stay in the system?

Sandostatin immediate-release form stays in the system for about 90 minutes half-life. The long-acting Sandostatin LAR has much longer Wirkung, ranging from weeks to months.

Sandostatin immediate-release is subcutaneous daily injections, while Sandostatin LAR is intramuscular every month.